Observational studyReproductive biology and endocrinology : RB&E2025
Epigenetic age and fertility timeline: testing an epigenetic clock to forecast in vitro fertilization success rate.
Observational study in Reproductive biology and endocrinology : RB&E, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- DNMT/TET Imbalance and Network-Level DNA Methylation Remodeling in Ovarian Aging: Mechanistic Perspectives.Biology · 2026Review
- Clinical Implications of Paternal Age in Assisted Reproduction: Integrating Sperm Epigenetic Evidence.Journal of clinical medicine · 2026Review
- Advances in multi-omics and aging clock research for female reproductive health and aging.MedScience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundIn the field of in vitro fertilization (IVF), the search for reliable success predictors is ongoing, with novel biomarkers gaining increasing attention. Epigenetic clocks, mathematical models based on DNA methylation (DNAm) patterns, have revolutionized aging research by providing insights into biological aging. However, the magnitude of the benefit of the use of a simplified and non-specific epigenetic clock is still insufficient to claim for its clinical use. We investigated the potential role of epigenetic clocks in predicting IVF success.
methodsThis prospective observational study involved 379 women of reproductive age who underwent IVF treatment. On the day of recruitment, blood samples were collected, and genomic DNA was isolated from white blood cells. Epigenetic age was calculated using an algorithm based on the methylation patterns of 5 specific CpG sites and derived by pyrosequencing technique ("Zbieć-Piekarska2" model). Epigenetic age acceleration (EPA) was estimated from the residuals of a linear model, with epigenetic age regressed on chronological age. We compared the resulting epigenetic age and EPA between women who achieved a live birth and those who did not, alongside traditional ovarian reserve parameters (antral follicular count AFC; anti-müllerian hormone AMH).
resultsAmong 379 women, 204 (54%) achieved LB. They were younger, had better ovarian reserve markers, retrieved more oocytes and had lower epigenetic age (36 ± 5 vs. 39 ± 5 years, p < 0.001) with moderate predictive power (area under the curve AUC = 0.652). After adjusting for antral follicular count (AFC), epigenetic age remained significantly associated with live birth (adjusted odds ratio OR = 0.91 per year; p < 0.001), suggesting IVF success is more likely in epigenetically younger women, beyond their ovarian reserve. This association was lost in subgroup analysis by infertility cause. In women aged 31-35, epigenetic age and EPA were the best predictors (AUC = 0.637). Combining epigenetic age with ovarian reserve markers slightly improved predictive accuracy (AUC = 0.692 with AFC, 0.693 with AMH) over chronological age alone (AUC = 0.672).
conclusionsEpigenetic clocks may enhance IVF success prediction, particularly in women between 31 and 35. Our findings support the need for further research in this area and emphasize the importance of developing epigenetic models specifically tailored to fertility outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.